FDA Approves Abemaciclib (Verzenio) for Advanced HR+ Breast Cancer - Medscape

Medscape

FDA Approves Abemaciclib (Verzenio) for Advanced HR+ Breast Cancer Medscape The US Food and Drug Administration (FDA) today approved abemaciclib (Verzenio, Eli Lilly) for the treatment of hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative advanced or metastatic breast cancer that has ... FDA approves new treatment for certain advanced or metastatic breast cancersFDA.gov FDA Approves Lilly Pill for Common Advanced Breast CancerU.S. News & World Report Third CDK Blocker Approved for Breast CancerMedPage Today Curetoday.com -Healio -Reuters -Monthly Prescribing Reference (registration) all 23 news articles »

from Health - Google News http://ift.tt/2fCfJHv